Bicara Therapeutics hires Replimune, Sanofi alum as chief commercial officer

As Bicara Therapeutics lines up for a potential accelerated cancer drug approval next year, the biotech has appointed Chris Sarchi as its chief commercial officer.

Nội dung đang được cập nhật.